BamSEC and AlphaSense Join Forces
Learn More

Lexicon Pharmaceuticals Inc. – Material Contracts

NASDAQ: LXRX    
Share price (6/3/26): $1.85    
Market cap (6/3/26): $822 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 4 pages Material contract
12/34/56
EX-10.1
from 8-K 5 pages Material contract
12/34/56
EX-10.6
from 10-K 5 pages Stock Option Agreement
12/34/56
EX-10.2
from 8-K 34 pages Preferred Stock Purchase Agreement Dated as of January 29, 2026 by and Among Lexicon Pharmaceuticals, Inc. and Artal Participations S.À R.L
12/34/56
EX-10.1
from 8-K 8 pages Purchase Agreement
12/34/56
EX-10.2
from 8-K 4 pages Material contract
12/34/56
EX-10.1
from 8-K 5 pages Material contract
12/34/56
EX-10.1
from 10-Q 22 pages Material contract
12/34/56
EX-10.1
from 8-K 6 pages Material contract
12/34/56
EX-10.15
from 10-K 13 pages Material contract
12/34/56
EX-10.12
from 10-K 5 pages Restricted Stock Unit Agreement
12/34/56
EX-10.11
from 10-K 5 pages Stock Option Agreement
12/34/56
EX-10.1
from 10-K 5 pages Material contract
12/34/56
EX-10.1
from 8-K 2 pages December 17, 2024 Start Date We Expect That You Will Begin Work on January 2, 2025. Base Salary You Will Receive a Monthly Salary of $37,500 ($450,000 Per Year), Paid in Accordance With Our Standard Payroll Policies and Subject to All Withholdings and Deductions as Required by Applicable Law. We Currently Pay Employees on the 15th and Last Day of Each Month. Cash Bonus Initial Stock Option Award
12/34/56
EX-10.2
from 8-K 6 pages We Are Pleased to Invite You to Become a Consultant to Lexicon Pharmaceuticals, Inc. (Which, Together With Its Subsidiaries and Affiliates, Is Referred to as the “Company” or “Lexicon”). the Purpose of This Letter Agreement (This “Agreement”) Is to Set Forth Our Mutual Understanding of the Terms and Conditions Under Which You Will Provide Consulting Services to the Company, as Set Forth Below
12/34/56
EX-10.1
from 8-K 4 pages The Purpose of This Letter Is to Confirm Our Agreement Concerning Your Resignation as President and Chief Operating Officer of Lexicon Pharmaceuticals, Inc. (The “Company”)
12/34/56
EX-10.3
from 10-Q 72 pages Material contract
12/34/56
EX-10.1
from 8-K 4 pages July 2, 2024 Base Salary You Will Receive a Monthly Salary of $53,000 ($636,000 Per Year), Paid in Accordance With Our Standard Payroll Policies and Subject to All Withholdings and Deductions as Required by Applicable Law. We Currently Pay Employees on the 15th and Last Day of Each Month. Cash Bonus
12/34/56
EX-10.10
from 10-K 4 pages Restricted Stock Unit Agreement
12/34/56
EX-10.6
from 10-K 1 page Summary of Non-Employee Director Compensation
12/34/56